Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$9.14 USD
-0.03 (-0.33%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $9.13 -0.01 (-0.11%) 7:52 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For TBPH
-
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
-
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
-
Theravance Bio: Q4 Earnings Snapshot
-
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
-
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?
-
Theravance's (TBPH) Q3 Loss Narrows, Revenues Beat Marginally
-
Theravance Bio: Q3 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Theravance Bio (TBPH) Down 2.3% Since Last Earnings Report: Can It Rebound?
-
Theravance's (TBPH) Q2 Earnings Beat Estimates, Revenues Miss
-
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
-
Theravance Bio: Q2 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Why Is Theravance Bio (TBPH) Down 3.8% Since Last Earnings Report?
-
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates
-
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
-
Theravance Bio: Q1 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
Earnings Preview: Theravance Biopharma (TBPH) Q1 Earnings Expected to Decline
-
Theravance Bio (TBPH) Down 2% Since Last Earnings Report: Can It Rebound?
-
Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates
-
Theravance Biopharma (TBPH) Reports Q4 Loss, Lags Revenue Estimates
-
Theravance Bio: Q4 Earnings Snapshot
-
Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update